Common use of Development and Commercialization Licenses Clause in Contracts

Development and Commercialization Licenses. (a) Subject to the terms and conditions of this Agreement [**], ▇▇▇▇▇▇ hereby grants to Millennium a worldwide, co-exclusive (with ▇▇▇▇▇▇) license, under ▇▇▇▇▇▇'▇ rights to the Program Intellectual Property, to (i) Develop and Manufacture Joint DDCs for use as Joint Products; (ii) make, have made (subject, in the case of any sublicense, to the provisions of Section 8.3), use, sell, offer for sale, import and export Joint Products in the Territory; and (iii) undertake such other activities as may be necessary in furtherance of the Development Program and the Commercialization Program. Such license shall carry an obligation of profit-sharing Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. with respect to Joint Products sold in the Territory, as set forth in Section 9.1. Such license shall further include the right to grant sublicenses to Affiliates of Millennium and to Third Parties in accordance with the terms set forth in Section 8.3. For purposes of clarity, ▇▇▇▇▇▇'▇ co-exclusive right retained under this Section 8.2.2(a) includes the right to grant sublicenses to Affiliates of ▇▇▇▇▇▇ and to Third Parties in accordance with the terms set forth in Section 8.3. (b) Subject to the terms and conditions of this Agreement (including, but not limited to, the exclusivity provisions of Section 2.1.

Appears in 1 contract

Sources: Collaboration and License Agreement (Millennium Pharmaceuticals Inc)

Development and Commercialization Licenses. (a) Subject to the terms and conditions of this Agreement [**], Millennium hereby grants to ▇▇▇▇▇▇ hereby grants to Millennium a worldwide, co-exclusive (with ▇▇▇▇▇▇Millennium) license, under ▇▇▇▇▇▇'▇ Millennium's rights to the Program Intellectual Property, to (i) Develop and Manufacture Joint DDCs for use as Joint Products; (ii) make, have made (subject, in the case of any sublicense, to the provisions of Section 8.3), use, sell, offer for sale, import and export Joint Products in the Territory; and (iii) undertake such other activities as may be necessary in furtherance of the Development Program and the Commercialization Program. Such license shall carry an obligation of profit-sharing Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. with respect to Joint Products sold in the Territory, as set forth in Section 9.1. Such license shall further include the right to grant sublicenses to Affiliates of Millennium ▇▇▇▇▇▇ and to Third Parties in accordance with the terms set forth in Section 8.3. For purposes of clarity, ▇▇▇▇▇▇'▇ Millennium's co-exclusive right retained under this Section 8.2.2(a8.1.2(a) includes the right to grant sublicenses to Affiliates of ▇▇▇▇▇▇ Millennium and to Third Parties in accordance with the terms set forth in Section 8.3. (b) Subject to the terms and conditions of this Agreement (including, but not limited to, the exclusivity provisions of Section 2.1.

Appears in 1 contract

Sources: Collaboration and License Agreement (Millennium Pharmaceuticals Inc)